| Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Myopathy -Increased liver enzymes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Absolute: liver disease Relative: use with certain drugs (P450)
 Pregnancy (women wanting to get preg should be removed off of statins 6-12 months in advance)
 |  | 
        |  | 
        
        | Term 
 
        | 4 Statins with least drug-drug interactions |  | Definition 
 
        | -Pravastatin -Fluvastatin
 -Rosuvastatin
 -Pitavastatin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Cholestyramine -Colestipol
 -Colesevelam
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -GI distress -Constipation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Raised TG (especially >400 mg/dL) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increases levels of: Digoxin, Warfarin, Thyroxine, and Thiazides
 |  | 
        |  | 
        
        | Term 
 
        | Nicotinic Acid Side effects |  | Definition 
 
        | Flushing, hyperglycemia, hyperuricemia, upper GI distress, hepatoxicity |  | 
        |  | 
        
        | Term 
 
        | Nicotinic Acid Contraindications |  | Definition 
 
        | Liver disease (use w/ caution), severe gout, peptic ulcer, uncontrolled diabetes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | First line agent or an alternative for tx of Hypertriglyceridemia and Diabetic hyperlipidemia. |  | 
        |  | 
        
        | Term 
 
        | Nicotinic Acid: cutaneous flushing and itching |  | Definition 
 
        | Appears to be prostaglandin mediated and can be reduced by aspirin 325mg given 30 mins before Niacin ingestion. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Produces large reductions in LDL and increases in HDL. |  | 
        |  | 
        
        | Term 
 
        | Niacin associated Hepatitis |  | Definition 
 
        | More common wtih sustained release preparations. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Gemfibrozil -Fenofibrate
 -Fenofibric Acid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dyspepsia, gallstones, myopathy (slight myopathy) |  | 
        |  | 
        
        | Term 
 
        | Fibric Acid Contraindications |  | Definition 
 
        | Severe renal or hepatic disease |  | 
        |  | 
        
        | Term 
 
        | Fenofibric Acid and Statins COMBO |  | Definition 
 
        | Reduces TG levels and increases HDL levels in pt with mixed dyslipidemia and CHD or a CHD equivalent. |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lowers LDL, May raise HDL, Doesnt have anything to do with TG |  | 
        |  | 
        
        | Term 
 
        | Ezetimibe Contraindications |  | Definition 
 
        | -Hypersensitivity -Pts with active liver disease or unexplained persistent elevations in serum transaminases (AST, ALT)
 -Pregnant and nursing women
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Omega-3 fatty acids -EPA
 -DHA
 
 Approved by FDA for the tx of high triglyceride levels
 
 NOT used as monotherapy, ,ALWAYS used as adjunctive therapy.
 |  | 
        |  | 
        
        | Term 
 
        | Lovaza (fish oil) Side effects |  | Definition 
 
        | GI (burping, taste perversion, dyspepsia) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atorvastatin + Amlodipine |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Statins Monitoring Parameters |  | Definition 
 
        | Baseline: Lipids, LFT's, CPK 
 Test @ 6wk: Lipids, LFT's
 
 Maintenance: Lipids and LFT's
 |  | 
        |  | 
        
        | Term 
 
        | Niacin Monitoring Parameters |  | Definition 
 
        | Baseline: Lipids, LFT's, Glucose 
 Test @ 6wk: Lipids, LFT's, Glucose
 
 Maintenance: Lipids and LFT's
 |  | 
        |  | 
        
        | Term 
 
        | Fibrates Monitoring Parameters |  | Definition 
 
        | Baseline: Lipids, LFT's, CBC 
 Test @ 6wk: Lipids, LFT's, CBC
 
 Maintenance: Lipid and LFT's, CBC
 |  | 
        |  | 
        
        | Term 
 
        | BAS Monitoring Parameters |  | Definition 
 
        | Baseline: Lipids 
 Test @ 6wk: Lipids
 
 Maintenance: Lipids
 |  | 
        |  | 
        
        | Term 
 
        | Simvastatin with Fibrates & Nictonic Acid |  | Definition 
 
        | Lower the dose of Simvastatin (max dose should be 10mg of Simvastatin when using with these drugs) |  | 
        |  | 
        
        | Term 
 
        | Simvastatin with Amiodarone or Verapamil |  | Definition 
 
        | Max dose of Simvastatin is 20mg when used with these drugs. |  | 
        |  | 
        
        | Term 
 
        | Rosuvastatin with Fibrates and Nicotinic Acid |  | Definition 
 
        | Lower dose of rosuvastatin when using fibrates and nicotinic acid, EXCEPT for fenofibrate (Tricor) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Clinical CHD -Symptomatic carotid artery disease
 -Peripheral arterial disease
 -Abdominal aortic aneurysm
 |  | 
        |  |